Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features (Q81965976)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Felix Chun

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

11

Pierre I Karakiewicz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

4

Markus Graefen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

5

Paul Perrotte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

8

Hartwig Huland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

10

Francesco Montorsi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

6

Thorsten Schlomm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1

Nazareno Suardi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Alexander Haese

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Andreas Erbersdobler

series ordinal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

1 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

2068-2072

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

Active surveillance for prostate cancer: for whom?

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

EAU guidelines on prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Early outcomes of active surveillance for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Prostate cancer-specific survival in men treated with hormonal therapy after failure of radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Stage migration and grade inflation in prostate cancer: Will Rogers meets Garrison Keillor.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Stage migration in clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23827

7 January 2021

Identifiers

DOI

10.1002/CNCR.23827

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18792067%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference